TV-1106
TV1106-IMM-20001
Phase 3 small_molecule terminated
Quick answer
TV-1106 for Growth Hormone-Deficiency is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Growth Hormone-Deficiency
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated